Peripheral Neuropathy Trial, Recruiting NCT04695834 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT04695834
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to give written consent to take part, or who have a legal representative who can do so on their behalf
  • People who have been diagnosed through nerve conduction testing with a trapped peroneal nerve (a nerve near the knee) and have had foot drop (difficulty lifting the front part of the foot) lasting roughly 6 to 14 weeks, with significant weakness measured by a standard scale
  • People who have had an ultrasound or MRI scan to rule out a growth or mass pressing on the nerve
  • People who are 18 years of age or older

Who may not be able to join:

  • People whose peroneal nerve injury was caused by a physical accident or by a medical procedure
  • People whose nerve problem is caused by a cyst, tumour, or other growth pressing on the nerve
  • People whose peroneal nerve is trapped at a location other than the area near the top of the lower leg bone (fibular head)
  • People whose mental or physical condition would prevent them from taking part in a physiotherapy program
  • People with a psychiatric illness
  • People who are pregnant
  • People who are planning to move to another country within one year of joining the trial
  • People who have had foot drop before this current episode
  • People who are permanently confined to bed
  • People with a history of neurological or musculoskeletal conditions that could affect foot drop or walking assessments — for example, nerve disease affecting multiple nerves, a history of stroke, or previous ankle surgery (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tom Theys, M.D.; Ph.D., Univeristy hospitals of Leuven

Phone: +3216344290

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
28 April 2021
Est. completion
31 December 2027

Where this trial is recruiting

🇧🇪 Belgium 🇳🇱 Netherlands

Primary endpoints

The difference in distance covered in meters during the six-minute walk test (6MWD) between baseline and 9 months after randomization.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov